- Collisson, Eric;
- Korkola, JE;
- Collisson, EA;
- Heiser, L;
- Oates, C;
- Bayani, N;
- Itani, S;
- Esch, A;
- Thompson, W;
- Griffith, OL;
- Wang, NJ
© 2015 Korkola et al.We report here on experimental and theoretical efforts to determine how best to combine drugs that inhibit HER2 and AKT in HER2+ breast cancers. We accomplished this by measuring cellular and molecular responses to lapatinib
